UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

The peripheral CD138+ population but not the CD138− population contains myeloma clonogenic cells in plasma cell leukaemia patients

British journal of haematology, 2012-03, Vol.156 (5), p.679-683

2012

Volltextzugriff (PDF)

Prognostic factors for survival and response after high‐dose therapy and autologous stem cell transplantation in systemic AL amyloidosis: a report on 21 patients

British journal of haematology, 1998-06, Vol.101 (4), p.766-769

1998

Volltextzugriff (PDF)

Increased and highly stable levels of functional soluble interleukin‐6 receptor in sera of patients with monoclonal gammopathy

European journal of immunology, 1993-04, Vol.23 (4), p.820-824

1993

Volltextzugriff (PDF)

IL‐6 up‐regulates Mcl‐1 in human myeloma cells through JAK / STAT rather than Ras / MAP kinase pathway

European journal of immunology, 1999-12, Vol.29 (12), p.3945-3950

1999

Volltextzugriff (PDF)

The imbalance between Survivin and Bim mediates tumour growth and correlates with poor survival in patients with multiple myeloma

British journal of haematology, 2009-04, Vol.145 (2), p.180-189

2009

Volltextzugriff (PDF)

Chromosome 13 abnormalities in multiple myeloma are mostly monosomy 13

British journal of haematology, 2000-12, Vol.111 (4), p.1116-1117

2000

Volltextzugriff (PDF)

High amounts of circulating interleukin (IL)‐6 in the form of monomeric immune complexes during anti‐IL‐6 therapy. Towards a new methodology for measuring overall cytokine production in human in vivo

European journal of immunology, 1992-11, Vol.22 (11), p.2819-2824

1992

Volltextzugriff (PDF)

The imbalance between Bim and Mcl‐1 expression controls the survival of human myeloma cells

European journal of immunology, 2004-11, Vol.34 (11), p.3156-3164

2004

Volltextzugriff (PDF)

Endogenous association of Bim BH3‐only protein with Mcl‐1, Bcl‐xL and Bcl‐2 on mitochondria in human B cells

European journal of immunology, 2005-03, Vol.35 (3), p.971-976

2005

Volltextzugriff (PDF)

High incidence of N and K-Ras activating mutations in multiple myeloma and primary plasma cell leukemia at diagnosis

Human mutation, 2001-09, Vol.18 (3), p.212-224

2001

Volltextzugriff (PDF)

Zoledronate Is a Potent Inhibitor of Myeloma Cell Growth and Secretion of IL‐6 and MMP‐1 by the Tumoral Environment

Journal of bone and mineral research, 1999-12, Vol.14 (12), p.2048-2056

1999

Volltextzugriff (PDF)

Solitary myeloma: Clinical and prognostic features of a review of 114 cases

Cancer, 1981-08, Vol.48 (3), p.845-851

1981

Volltextzugriff (PDF)

CD38 expression and secondary 17p deletion are important  prognostic factors in chronic lymphocytic leukaemia

British journal of haematology, 2002-01, Vol.116 (1), p.142-150

2002

Volltextzugriff (PDF)

Lack of CD27 in myeloma delineates different presentation and outcome

British journal of haematology, 2006-01, Vol.132 (2), p.168-170

2006

Volltextzugriff (PDF)

Mcl‐1 and Bcl‐xL are co‐regulated by IL‐6 in human myeloma cells

British journal of haematology, 1999-11, Vol.107 (2), p.392-395

1999

Volltextzugriff (PDF)

Endogenous association of Bim BH3‐only protein with Mcl‐1, Bcl‐x L and Bcl‐2 on mitochondria in human B cells

European journal of immunology, 2005-03, Vol.35 (3), p.971-976

2005

Volltextzugriff (PDF)

The cancer germ‐line genes MAGE‐1, MAGE‐3 and PRAME are commonly expressed by human myeloma cells

European journal of immunology, 2000-03, Vol.30 (3), p.803-809

2000

Volltextzugriff (PDF)

Criteria for the classification of monoclonal gammopathies, multiple myeloma and related disorders: a report of the International Myeloma Working Group

British journal of haematology, 2003-06, Vol.121 (5), p.749-757

2003

Volltextzugriff (PDF)

A combination of anti‐interleukin 6 murine monoclonal antibody with dexamethasone and high‐dose melphalan induces high complete response rates in advanced multiple myeloma

British journal of haematology, 2000-06, Vol.109 (3), p.661-664

2000

Volltextzugriff (PDF)

Interferon α extends the survival of human myeloma cells through an upregulation of the Mcl‐1 anti‐apoptotic molecule

British journal of haematology, 2001-02, Vol.112 (2), p.358-363

2001

Volltextzugriff (PDF)

Interleukin‐1 in multiple myeloma: producer cells and their role in the control of IL‐6 production

British journal of haematology, 1998-12, Vol.103 (4), p.1152-1160

1998

Volltextzugriff (PDF)

CD130 rather than CD126 expression is associated with disease activity in multiple myeloma

British journal of haematology, 1999-08, Vol.106 (2), p.532-535

1999

Volltextzugriff (PDF)

High incidence of cryptic translocations involving the Ig heavy chain gene in multiple myeloma, as shown by fluorescence in situ hybridization

Genes chromosomes & cancer, 1999-01, Vol.24 (1), p.9-15

1999

Volltextzugriff (PDF)

C‐reactive protein levels as a direct indicator of interleukin‐6 levels in humans in vivo

Arthritis and rheumatism, 1992-08, Vol.35 (8), p.982-983

1992

Volltextzugriff (PDF)

P53 deletion is not a frequent event in multiple myeloma

British journal of haematology, 1999-09, Vol.106 (3), p.717-719

1999

Volltextzugriff (PDF)

1 – 25 von 75

Suche als RSS-Feed

Aktive Filter

KollektionWiley Online Library

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(72)
Mit Volltextzugriff
(56)

Publikationsform

Artikel
(75)

Sprache

Englisch
(75)

Erscheinungsjahr

n.n

Thema

Humans
(60)
Life Sciences & Biomedicine
(47)
Science & Technology
(47)
Biological And Medical Sciences
(36)
Medical Sciences
(36)
Hematology
(30)
Female
(26)
Male
(24)
Middle Aged
(23)
Multiple Myeloma
(23)
Aged
(20)
Immunodeficiencies. Immunoglobulinopathies
(20)
Immunoglobulinopathies
(20)
Immunopathology
(20)
Tumor Cells, Cultured
(17)
Adult
(16)
Multiple Myeloma - Pathology
(15)
Multiple Myeloma - Genetics
(14)
Multiple Myeloma - Metabolism
(12)
Hematologic And Hematopoietic Diseases
(11)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

The peripheral CD138+ population but not the CD138− population contains myeloma clonogenic cells in plasma cell leukaemia patients

Prognostic factors for survival and response after high‐dose therapy and autologous stem cell transplantation in systemic AL amyloidosis: a report on 21 patients

Increased and highly stable levels of functional soluble interleukin‐6 receptor in sera of patients with monoclonal gammopathy

IL‐6 up‐regulates Mcl‐1 in human myeloma cells through JAK / STAT rather than Ras / MAP kinase pathway

The imbalance between Survivin and Bim mediates tumour growth and correlates with poor survival in patients with multiple myeloma

Chromosome 13 abnormalities in multiple myeloma are mostly monosomy 13

High amounts of circulating interleukin (IL)‐6 in the form of monomeric immune complexes during anti‐IL‐6 therapy. Towards a new methodology for measuring overall cytokine production in human in vivo

The imbalance between Bim and Mcl‐1 expression controls the survival of human myeloma cells

Endogenous association of Bim BH3‐only protein with Mcl‐1, Bcl‐xL and Bcl‐2 on mitochondria in human B cells

High incidence of N and K-Ras activating mutations in multiple myeloma and primary plasma cell leukemia at diagnosis

Zoledronate Is a Potent Inhibitor of Myeloma Cell Growth and Secretion of IL‐6 and MMP‐1 by the Tumoral Environment

Solitary myeloma: Clinical and prognostic features of a review of 114 cases

CD38 expression and secondary 17p deletion are important  prognostic factors in chronic lymphocytic leukaemia

Lack of CD27 in myeloma delineates different presentation and outcome

Mcl‐1 and Bcl‐xL are co‐regulated by IL‐6 in human myeloma cells

Endogenous association of Bim BH3‐only protein with Mcl‐1, Bcl‐x L and Bcl‐2 on mitochondria in human B cells

The cancer germ‐line genes MAGE‐1, MAGE‐3 and PRAME are commonly expressed by human myeloma cells

Criteria for the classification of monoclonal gammopathies, multiple myeloma and related disorders: a report of the International Myeloma Working Group

A combination of anti‐interleukin 6 murine monoclonal antibody with dexamethasone and high‐dose melphalan induces high complete response rates in advanced multiple myeloma

Interferon α extends the survival of human myeloma cells through an upregulation of the Mcl‐1 anti‐apoptotic molecule

Interleukin‐1 in multiple myeloma: producer cells and their role in the control of IL‐6 production

CD130 rather than CD126 expression is associated with disease activity in multiple myeloma

High incidence of cryptic translocations involving the Ig heavy chain gene in multiple myeloma, as shown by fluorescence in situ hybridization

C‐reactive protein levels as a direct indicator of interleukin‐6 levels in humans in vivo

P53 deletion is not a frequent event in multiple myeloma

Aktive Filter

Suchergebnisse filtern